London, England, June 14, 2024 (GLOBE NEWSWIRE) — Global surge in infectious diseases as over 40 countries report outbreaks 10-fold over pre-pandemic levels
New analysis by Airfinity and Bloomberg News reveals outbreaks of diseases such as measles, whooping cough, tuberculosis and polio, as well as dengue and cholera are surging worldwide.
Today’s study has compiled data from over 60 organisations and public health agencies showing that the world is seeing a resurgence of at least 13 infectious diseases, with cases higher than before the pandemic in many regions.
Over 40 countries or territories have reported at least one infectious disease resurgence that’s 10-fold or more over their pre-pandemic baseline.
The data is presented in an interactive spike map and available on our website. It shows outbreaks by disease with the spikes representing the fold change in reported cases between a post-pandemic year (2022-onwards) with highest reported incidence against a single pre-pandemic ‘baseline’ year within the 2017-2019 period, preceding the COVID-19 pandemic.
Our analysis reveals today’s outbreaks can be attributed to three main factors. The first is falling vaccination rates. Measles, polio, whooping cough (also known as pertussis) and tuberculosis are all vaccine-preventable. Declining uptake is leaving populations vulnerable and allowing the pathogens to spread. For example, global measles vaccination coverage has declined, with 20 countries in Europe falling below 90% in 2022, including the UK (87%), which is currently experiencing a national outbreak. For example, Austria is seeing its worst measles outbreak on record as cases in the first five months of 2024 are already 190% higher than the pre-pandemic peak. Countries like Denmark, Bosnia and Herzegovina, Canada, Ireland, Netherlands are on track to surpass pre-pandemic levels if sustained transmission persists.
There is some evidence that the current pertussis outbreaks could in part be driven by pressure on the bacteria to gain adaptations that may impact the effectiveness of current vaccines, or that this could be occurring due to genetic drift. With a 134% post-pandemic increase in cases in 2024, Spain is among the growing number of countries in Europe to see a rising whooping cough burden. France, Norway, and the UK are also expected to surpass pre-pandemic levels soon.
The second is an overall decline in population immunity during the pandemic years. Restrictions on social interactions suppressed the circulation of pathogens such as influenza, respiratory syncytial virus (RSV), Mycoplasma pneumoniae and invasive Group A Streptococcus, known as iGAS. Today’s resurgence can be attributed largely to more susceptible populations as well as increased testing and reporting of cases following the pandemic. For example, total influenza cases in the US last season were 28% higher than in 2019. In Europe, total influenza cases last season were 75% higher than in 2019.
The third factor is climate change which is enabling the spread of diseases such as dengue and cholera, and increasing the pathogens reach into new territories. Argentina has seen the largest rise with a 151-fold increase in dengue cases from 3,220 in 2019 to 488,035 so far this year. As mosquitos move northward, we have seen more cases in southern Europe. Italy has seen a significant increase with its first locally acquired case detected in 2020 to 67 cases in 2023. In France, there were 65 reported cases, up from 9 in 2019, a 7.2-fold increase.
Airfinity’s Biorisk analyst Kristan Piroeva says, “Unvaccinated children are at the greatest risk from the resurgence of diseases like measles, whooping cough, polio and RSV. These illnesses can often be more severe for infants and young children than the general adult population. Ensuring sufficient vaccination rates is crucial to preventing these vulnerable groups from becoming seriously ill”.
“Cases of dengue, which most people think of as a tropical disease, are growing in non-endemic countries. As temperatures continue to rise, we could see the disease becoming endemic in southern Europe. Airfinity’s global overview of dengue incidence shows nearly half the world’s population may now be at risk of dengue infection”.
“An increase in surveillance and testing for disease also plays a significant role in today’s analysis. By enhancing our monitoring capabilities, we can better track the spread of these diseases and implement timely interventions to mitigate their impact.”
Notes to the Editor:
Full methodology can be found on the interactive version of the map on our website.
* includes wild poliovirus type 1, vaccine-derived poliovirus types 1,2 and 3
** Invasive Group A Streptococcus
*** Mycoplasma pneumoniae